What’s Going On With Kyntra Bio Stock Tuesday?

Kyntra Bio Inc. (NASDAQ:KYNB), formerly Fibrogen, shares fluctuated in Tuesday’s premarket session as the company announced data from a Phase 1b/2 study of FG-3246 in combination with enzalutamide for treating metastatic castration-resistant prostate cancer. Astellas...